European Journal of Pharmacology

The European Journal of Pharmacology (EUR J PHARMACOL, ISSN 0014-2999) is a leading international peer-reviewed journal dedicated to the full spectrum of pharmacological research. Published by Elsevier, the journal serves as a premier forum for the dissemination of high-quality original research and authoritative reviews that advance the understanding of drug action mechanisms. Its scope encompasses experimental pharmacology, including molecular, cellular, systems, and behavioral pharmacology, with a strong emphasis on studies that elucidate the mechanisms of drug action, drug interactions, and the therapeutic potential of novel compounds. The journal publishes full-length research articles, rapid communications, and comprehensive review articles, alongside special issues focused on emerging topics in pharmacology. The target audience includes academic researchers, pharmaceutical scientists, pharmacologists, toxicologists, and clinicians seeking cutting-edge insights into drug development and pharmacological principles. The European Journal of Pharmacology is recognized for its rigorous peer-review process and high editorial standards. With a 2026 Impact Factor of 5.7000 and a JCR Quartile ranking of Q1, it consistently ranks among the top-tier journals in the Pharmacology & Pharmacy category. This standing reflects its substantial influence and the high citation impact of its published content. While primarily a subscription-based journal, it offers open access options for authors, ensuring that groundbreaking research can reach the widest possible audience. Its enduring reputation and broad readership make it an essential resource for the global pharmacology community.